Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Effector Therapeutics Completes Enrollment In Second Of Three Cohorts Of Phase 1B Clinical Trial Of Zotatifin For The Treatment Of Covid-19

Oct 26 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS COMPLETES ENROLLMENT IN SECOND OF
THREE
COHORTS OF PHASE 1B CLINICAL TRIAL OF ZOTATIFIN FOR THE
TREATMENT OF COVID-19

Source text for Eikon:  ID:nGNX2kJQ5F 
Further company coverage:  EFTR.O 
 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Effector Therapeutics

See all news